| P50 | author | Hye Soo Chung | Q55153735 |
| P2093 | author name string | Dong Seop Choi | |
| | Sin Gon Kim | |
| | Hyun Jung Lee | |
| | Nan Hee Kim | |
| | Sei Hyun Baik | |
| | Hye Jin Yoo | |
| | Kyung Mook Choi | |
| | Soon Young Hwang | |
| | Ju-Hee Choi | |
| | Ji-A Seo | |
| P2860 | cites work | Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement | Q74504095 |
| | Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice | Q77340592 |
| | The effects of caloric restriction on fetuin-A and cardiovascular risk factors in rats and humans: a randomized controlled trial | Q87446345 |
| | Inflammation and insulin resistance | Q22241893 |
| | Purification and primary amino acid sequence of a novel neutrophil chemotactic factor LECT2 | Q28115395 |
| | Nonalcoholic fatty liver disease: a systematic review | Q28263139 |
| | Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults | Q29614911 |
| | Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. | Q34331690 |
| | Combined effect of nonalcoholic fatty liver disease and impaired fasting glucose on the development of type 2 diabetes: a 4-year retrospective longitudinal study | Q34583419 |
| | The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines | Q34907937 |
| | Hepatokines as a Link between Obesity and Cardiovascular Diseases | Q35126823 |
| | LECT2 protects mice against bacterial sepsis by activating macrophages via the CD209a receptor | Q36547685 |
| | The Relationship between 10-Year Cardiovascular Risk Calculated Using the Pooled Cohort Equation and the Severity of Non-Alcoholic Fatty Liver Disease. | Q36717062 |
| | The adipocyte as an active participant in energy balance and metabolism | Q36820181 |
| | Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions | Q37532544 |
| | The role of hepatokines in metabolism | Q38075770 |
| | Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis | Q38090905 |
| | Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. | Q38205348 |
| | A dipeptidyl peptidase-IV inhibitor improves hepatic steatosis and insulin resistance by AMPK-dependent and JNK-dependent inhibition of LECT2 expression. | Q38841750 |
| | Hepatokines: unlocking the multi-organ network in metabolic diseases. | Q39000769 |
| | The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes | Q45834496 |
| | Increase in hepatic NKT cells in leukocyte cell-derived chemotaxin 2-deficient mice contributes to severe concanavalin A-induced hepatitis | Q47309667 |
| | LECT2 induces atherosclerotic inflammatory reaction via CD209 receptor-mediated JNK phosphorylation in human endothelial cells. | Q53448383 |
| | Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver. | Q54372891 |
| | LECT2 functions as a hepatokine that links obesity to skeletal muscle insulin resistance. | Q54381103 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | e0174717 | |
| P577 | publication date | 2017-04-04 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis | |
| P478 | volume | 12 | |